Alzheimer’s drug trial altered after 9 deaths (AP via Yahoo! News)
Tuesday, December 15th, 2009Elan Corp. Plc and Transition Therapeutics Inc. said Tuesday they’ve eliminated two of three doses used in a mid-stage study of a potential Alzheimer’s disease treatment after nine patients died while receiving the higher doses.
Read more:
... continue reading